Vertex's Non-Opioid Pain Drug Secures Coverage from UnitedHealth

Vertex Pharmaceuticals has marked a significant milestone in the pharmaceutical landscape by gaining coverage approval for its non-opioid pain management drug, known as exablate, from UnitedHealth Group. This development is seen as a promising step towards providing alternatives to patients who suffer from chronic pain conditions while mitigating the risks associated with opioid medications.

Continue reading

The Rising Trend of Ozempic Alternatives: Employers Now Eyeing Coverage for Weight Loss Medications

In a significant shift within the pharmaceutical landscape, the increasing popularity of Ozempic alternatives is attracting attention from employers who are considering extending insurance coverage for weight loss drugs. This development stems from a growing recognition of the health benefits associated with these medications, as well as their potential to mitigate obesity-related illnesses that can lead to higher healthcare costs for businesses.

Continue reading